DICER1-related tumor predisposition: genes and variants
Explore variant evidence for DICER1-related tumor predisposition across 1 analyzed protein (DICER1). Linked ClinVar records include 28 pathogenic or likely pathogenic variants, 1,730 variants of uncertain significance and 64 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to DICER1-related tumor predisposition
DICER1: Endoribonuclease Dicer
It cleaves precursor microRNAs into mature regulatory RNAs that guide post-transcriptional gene silencing. Germline pathogenic variants cause DICER1 tumor-predisposition syndrome, with increased risk of several rare childhood and young-adult tumors.
28 ClinVar pathogenic / likely pathogenic and 1,794 uncertain variants in DICER1 have source records linked to DICER1-related tumor predisposition. Association strength is not clinical gene validity.
Where DICER1-related tumor predisposition variants cluster
- DICER1 RNase III 2 (positions 1666–1824): 22 of 28 ClinVar pathogenic / likely pathogenic variants, 9.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to DICER1-related tumor predisposition
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| DICER1 G1809R | 1809 | RNase III 2 | Pathogenic / likely pathogenic (★★★) |
| DICER1 E1705K | 1705 | RNase III 2 | Pathogenic / likely pathogenic (★★★) |
| DICER1 D1810Y | 1810 | RNase III 2 | Pathogenic / likely pathogenic (★★★) |
| DICER1 E503D | 503 | Helicase C-terminal | Pathogenic / likely pathogenic (★★★) |
| DICER1 S1344L | 1344 | RNase III 1 | Pathogenic / likely pathogenic (★★) |
| DICER1 E1705V | 1705 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 E1705Q | 1705 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 E1705D | 1705 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1709C | 1709 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1709H | 1709 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1709V | 1709 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1709Y | 1709 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1709E | 1709 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 G1809W | 1809 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 G1809E | 1809 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1810N | 1810 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1810G | 1810 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1810V | 1810 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 E1813S | 1813 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 E1813V | 1813 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 E1813D | 1813 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 G1708R | 1708 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1713A | 1713 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 D1713N | 1713 | RNase III 2 | Pathogenic / likely pathogenic (★) |
| DICER1 G803R | 803 | Pathogenic / likely pathogenic (★) | |
| DICER1 I582F | 582 | Helicase C-terminal | Pathogenic / likely pathogenic (★) |
| DICER1 L805P | 805 | Pathogenic / likely pathogenic (★) | |
| DICER1 R245K | 245 | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in DICER1-related tumor predisposition
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| DICER1 E1813K | 1813 | RNase III 2 | Conflicting reports (★) | +7: 7 other pathogenic changes within 3 positions; E1813S at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.869 |
| DICER1 E1813Q | 1813 | RNase III 2 | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; E1813S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| DICER1 D1810H | 1810 | RNase III 2 | Uncertain (★★★) | +6: 10 other pathogenic changes within 3 positions; D1810Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| DICER1 E1813A | 1813 | RNase III 2 | Uncertain (★★★) | +6: 7 other pathogenic changes within 3 positions; E1813S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| DICER1 E1813G | 1813 | RNase III 2 | Uncertain (★★★) | +6: 7 other pathogenic changes within 3 positions; E1813S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| DICER1 G803E | 803 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; G803R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
Which prediction tools work for DICER1-related tumor predisposition
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaLR: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 99 out of 100
- PolyPhen-2: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 96 out of 100
- ESM1b (LLR): 95 out of 100
Diseases related to DICER1-related tumor predisposition
- Ovarian cancer, also linked to DICER1
Frequently asked questions
Which genes have records linked to DICER1-related tumor predisposition?
This view contains 1 analyzed proteins: DICER1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 28 pathogenic or likely pathogenic variants, 1,730 variants of uncertain significance and 64 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 6 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,910 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center